INMD - InMode Ltd.
NASDAQ
->
Healthcare
->
Medical Devices
Yokne'am,
Israel
Type: Equity
INMD price evolution
INMD
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $238.59 | $92 | $120.93 | $144.41 |
| Short term investments | $637.21 | $649.61 | $597.19 | |
| Net receivables | $65.22 | $41.25 | $36.54 | $46.03 |
| Inventory | $58.28 | $52.63 | $51.6 | $45.09 |
| Total current assets | $808.4 | $842.99 | $874.18 | $845.33 |
| Long term investments | $0.7 | $0.7 | $0.7 | |
| Property, plant & equipment | $10.97 | $11.64 | $11.92 | $12.08 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $16.84 | $17.55 | $17.96 | |
| Total investments | $637.91 | $650.31 | $597.89 | |
| Total assets | $824.03 | $859.84 | $891.74 | $863.29 |
| Current liabilities | ||||
| Accounts payable | $14.31 | $15.55 | $13.22 | $13.97 |
| Deferred revenue | $47.06 | $23.95 | $14.69 | |
| Short long term debt | ||||
| Total current liabilities | $75.7 | $97.69 | $65 | $64.14 |
| Long term debt | $5.67 | $6.21 | $6.61 | |
| Total noncurrent liabilities | $11.03 | $11.3 | $11.78 | |
| Total debt | $5.67 | $6.21 | $6.61 | |
| Total liabilities | $87.14 | $108.72 | $76.3 | $75.91 |
| Shareholders' equity | ||||
| Retained earnings | $693.43 | |||
| Other shareholder equity | $736.89 | $751.12 | $815.43 | -$1.68 |
| Total shareholder equity | $751.12 | $815.43 | $787.37 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $144.41 | $75.25 | $68.14 | $68.94 |
| Short term investments | $597.19 | $449.84 | $347.78 | $191.6 |
| Net receivables | $46.03 | $42.09 | $33.94 | $17.45 |
| Inventory | $45.09 | $39.9 | $21.03 | $14.98 |
| Total current assets | $845.33 | $629.37 | $470.11 | $289.59 |
| Long term investments | $0.7 | $0.6 | $0.6 | $0.6 |
| Property, plant & equipment | $12.08 | $7.37 | $5.72 | $2.13 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $17.96 | $15.04 | $8.43 | $6.17 |
| Total investments | $597.89 | $450.44 | $348.38 | $192.2 |
| Total assets | $863.29 | $644.41 | $478.54 | $295.76 |
| Current liabilities | ||||
| Accounts payable | $13.97 | $16.24 | $8.78 | $6.41 |
| Deferred revenue | $14.69 | $17.76 | $16.56 | $13.89 |
| Short long term debt | ||||
| Total current liabilities | $64.14 | $82.02 | $51.85 | $35.03 |
| Long term debt | $6.61 | $3.51 | $3.31 | $0.36 |
| Total noncurrent liabilities | $11.78 | $7.77 | $10.89 | $5.26 |
| Total debt | $6.61 | $3.51 | $3.31 | $0.36 |
| Total liabilities | $75.91 | $89.79 | $62.74 | $40.29 |
| Shareholders' equity | ||||
| Retained earnings | $693.43 | $495.51 | $333.99 | $169.02 |
| Other shareholder equity | -$1.68 | -$7.49 | -$1.32 | $0.36 |
| Total shareholder equity | $787.37 | $554.62 | $415.8 | $255.47 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $86.45 | $80.28 | $126.78 | |
| Cost of revenue | $17.12 | $16.36 | $20.26 | |
| Gross Profit | $69.33 | $63.92 | $106.52 | |
| Operating activities | ||||
| Research & development | $3.7 | $3.52 | $3.47 | |
| Selling, general & administrative | $47.32 | $42.31 | $51.8 | |
| Total operating expenses | $51.02 | $45.83 | $55.27 | |
| Operating income | $18.31 | $18.09 | $51.24 | |
| Income from continuing operations | ||||
| EBIT | $27 | $26.08 | $60.16 | |
| Income tax expense | $3.19 | $2.38 | $5 | |
| Interest expense | ||||
| Net income | ||||
| Net income | $23.82 | $23.7 | $55.16 | |
| Income (for common shares) | $23.82 | $23.7 | $55.16 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $492.05 | $454.27 | $357.56 | $206.11 |
| Cost of revenue | $80.71 | $73.48 | $53.59 | $30.85 |
| Gross Profit | $411.34 | $380.79 | $303.97 | $175.26 |
| Operating activities | ||||
| Research & development | $13.41 | $12.43 | $9.53 | $9.47 |
| Selling, general & administrative | $202.27 | $170.51 | $127.76 | $92.95 |
| Total operating expenses | $215.68 | $182.93 | $136.5 | $102.42 |
| Operating income | $195.66 | $197.85 | $167.48 | $72.84 |
| Income from continuing operations | ||||
| EBIT | $217.27 | $201.47 | $167.9 | $76.14 |
| Income tax expense | $19.35 | $39.95 | $2.93 | $1.11 |
| Interest expense | ||||
| Net income | ||||
| Net income | $197.92 | $161.52 | $164.97 | $75.03 |
| Income (for common shares) | $197.92 | $161.52 | $164.97 | $75.03 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $23.82 | $23.7 | $55.16 | |
| Operating activities | ||||
| Depreciation | $0.18 | $0.17 | $0.12 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $5.16 | $3.98 | $6.32 | |
| Total cash flows from operations | $42.06 | $24.11 | $61.17 | |
| Investing activities | ||||
| Capital expenditures | -$0.25 | -$0.11 | -$0.02 | |
| Investments | $17.97 | -$47.28 | -$51.57 | |
| Total cash flows from investing | $84.39 | $17.73 | -$47.39 | -$51.59 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$88.98 | |||
| Net borrowings | ||||
| Total cash flows from financing | -$164.34 | -$88.58 | $0.23 | $0.28 |
| Effect of exchange rate | $0.16 | -$0.13 | -$0.44 | $0.83 |
| Change in cash and equivalents | $20.43 | -$28.93 | -$23.48 | $10.68 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $197.92 | $161.52 | $164.97 | $75.03 |
| Operating activities | ||||
| Depreciation | $0.62 | $0.68 | $0.52 | $0.42 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $23.6 | $24.45 | $11.96 | $12.85 |
| Total cash flows from operations | $176.83 | $181.58 | $174.88 | $79.22 |
| Investing activities | ||||
| Capital expenditures | -$0.7 | -$1.57 | -$0.94 | -$0.46 |
| Investments | -$135.36 | -$107.9 | -$159.17 | -$42.84 |
| Total cash flows from investing | -$136.06 | -$109.47 | -$160.11 | -$43.3 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$42.64 | -$35.37 | -$17.22 | |
| Net borrowings | ||||
| Total cash flows from financing | $5.5 | -$41.09 | -$15.02 | -$12.44 |
| Effect of exchange rate | $0.6 | -$1.61 | -$0.56 | $0.73 |
| Change in cash and equivalents | $46.87 | $29.4 | -$0.8 | $24.21 |
News
Fundamentals
| Market cap | $1.19B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 82.64M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 2.89 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.10 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 10.68 |
| Quick ratio | 9.91 |